DENTSPLY SIRONA Inc.

Listed Company

XRAYCIK 0000818479NasdaqLarge AcceleratedDental Equipment & SuppliesDelawareFY ends Dec 31

Period

FY 2025

Revenue

$3.68B

Net Income

$-598.00M

Total Assets

$5.43B

Equity

$1.34B

Shares Out

199.75M

Op. Cash Flow

$235.00M

Business

DENTSPLY SIRONA Inc. is a diversified manufacturer and marketer of professional dental products, technologies and healthcare consumables for urology and enterology. The Company offers dental technology and equipment, dental implants, clear aligners, restorative and preventive consumables, digital CAD/CAM systems, cloud-enabled services (DS Core), and continence care products. It operates through four reportable segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. Dentsply Sirona sells its products globally through third-party distributors, direct sales to dental professionals and laboratories, and digital platforms across approximately 150 countries.

Summary from filing dated 2025-02-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net sales	3,680	3,793	3,965	3,922	4,231
Cost of products sold	1,840	1,835	1,879	1,795	1,884
Gross profit	1,840	1,958	2,086	2,127	2,347
Selling, general, and administrative expenses	1,438	1,605	1,613	1,589	1,551
Research and development expenses	150	165	184	174	171
Goodwill and intangible asset impairments	650	1,014	307	1,287	0
Restructuring costs	24	53	67	14	17
Operating loss	−422	−879	−85	−937	608
Interest expense, net	88	69	81	65	—
Other (income) expense, net	−24	−12	9	53	2
Loss before income taxes	−486	−936	−175	−1,055	545
Provision (benefit) for income taxes	112	−26	−43	−105	134
Net loss	−598	−910	−132	−950	411
Less: Net loss attributable to noncontrolling interests	0	0	0	0	0
Net loss attributable to Dentsply Sirona	−598	−910	−132	−950	411
Basic (in dollars per share)	−3	−4.48	−0.62	−4.41	1.88
Diluted (in dollars per share)	−3	−4.48	−0.62	−4.41	1.87
Basic (in shares)	199	203	212	216	218
Diluted (in shares)	199	203	212	216	220

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2023 2023-06-30	FY 2023 2023-03-31
Cash and cash equivalents	326	272	334	—	—
Accounts and notes receivable-trade, net	688	556	695	—	—
Inventories, net	642	564	624	—	—
Prepaid expenses and other current assets	367	354	320	—	—
Total Current Assets	2,023	1,746	1,973	—	—
Property, plant and equipment, net	861	766	800	—	—
Operating lease right-of-use assets, net	139	136	178	—	—
Identifiable intangible assets, net	974	1,207	1,705	—	—
Goodwill, net	1,148	1,597	2,438	2,703	2,701
Other noncurrent assets	284	301	276	—	—
Total Assets	5,429	5,753	7,370	—	—
Accounts payable	300	241	305	—	—
Accrued liabilities	700	754	749	—	—
Income taxes payable	30	45	49	—	—
Notes payable and current portion of long-term debt	313	549	322	—	—
Total Current Liabilities	1,343	1,589	1,425	—	—
Long-term debt	2,015	1,586	1,796	—	—
Operating lease liabilities	93	91	125	—	—
Deferred income taxes	94	129	228	—	—
Other noncurrent liabilities	544	415	502	—	—
Total Liabilities	4,089	3,810	4,076	—	—
Commitments and contingencies (Note 21)	—	—	—	—	—
Preferred stock, $1.00 par value; 0.25 million shares authorized; no shares issued	0	0	0	—	—
Common stock, $0.01 par value; 400.0 million shares authorized at December 31, 2024 and 2023 264.5 million shares issued at December 31, 2024 and 2023 198.8 million and 207.2 million shares outstanding at December 31, 2024 and 2023, respectively	3	3	3	—	—
Capital in excess of par value	6,644	6,640	6,643	—	—
Accumulated deficit	−1,564	−835	205	—	—
Accumulated other comprehensive loss	−639	−730	−636	—	—
Treasury stock, at cost, 64.9 million and 65.7 million shares at December 31, 2025 and 2024, respectively	−3,105	−3,136	−2,922	—	—
Total Dentsply Sirona Equity	1,339	1,942	3,293	—	—
Noncontrolling interests	1	1	1	—	—
Total Equity	1,340	1,943	3,294	—	—
Total Liabilities and Equity	5,429	5,753	7,370	—	—

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation	141	133	132	119	124
Amortization of intangible assets	211	216	211	209	222
Goodwill impairment	525	773	291	1,187	0
Intangible asset impairment	125	241	16	100	0
Deferred income taxes	30	−136	−130	−228	−25
Stock-based compensation expense	33	39	46	59	48
Other non-cash (income) expense	−10	−9	2	60	24
Loss (gain) on disposal of property, plant and equipment	0	19	−3	3	—
Accounts and notes receivable-trade, net	−91	104	−58	85	−117
Inventories, net	−17	17	6	−141	−64
Prepaid expenses and other current assets	−7	38	−58	−33	−32
Other noncurrent assets	−7	−5	4	1	−10
Accounts payable	11	−30	14	30	−49
Accrued liabilities	−74	−39	17	−6	117
Income taxes	−32	38	−11	−15	17
Other noncurrent liabilities	−5	−28	30	1	12
Net cash provided by operating activities	235	461	377	517	657
Cash received on sale of non-strategic businesses or product lines	0	0	13	0	28
Capital expenditures	−131	−180	−149	−149	−142
Cash received on derivative contracts	10	1	39	13	2
Cash paid on derivative contracts	−14	−12	0	0	—
Other investing activities, net	3	−6	8	−2	2
Net cash used in investing activities	−132	−197	−89	−138	−358
Proceeds from long-term borrowings	553	1	0	6	16
Cash paid for deferred financing costs	−16	0	0	—	—
Repayments on long-term borrowings	−147	−88	−7	−2	−297
Proceeds from 364-day bridge loan	435	0	0	—	—
Repayment of 364-day bridge loan	−435	0	0	—	—
(Repayments) proceeds on other short-term borrowings, net	−336	177	126	—	—
Cash paid for treasury stock	0	−250	−300	−150	−200
Cash dividends paid	−128	−126	−116	−104	−92
Other financing activities, net	−6	−16	−10	−15	−36
Net cash used in financing activities	−80	−302	−307	−329	−379
Effect of exchange rate changes on cash and cash equivalents	31	−24	−12	−24	−19
Net (decrease) increase in cash and cash equivalents	54	−62	−31	26	−99
Interest paid, net of amounts capitalized	66	91	97	70	64
Income taxes paid, net of refunds	71	74	177	122	148
Change in accounts payable related to capital expenditures	37	8	6	−6	19
Exchange of inventory for naming rights	14	0	0	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro